145 related articles for article (PubMed ID: 16461359)
1. A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein.
Qin Q; Inatome R; Hotta A; Kojima M; Yamamura H; Hirai H; Yoshizawa T; Tanaka H; Fukami K; Yanagi S
J Cell Biol; 2006 Feb; 172(4):497-504. PubMed ID: 16461359
[TBL] [Abstract][Full Text] [Related]
2. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.
Fu L; Gao YS; Sztul E
Neurobiol Dis; 2005 Dec; 20(3):656-65. PubMed ID: 15964198
[TBL] [Abstract][Full Text] [Related]
4. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
Condemine W; Takahashi Y; Le Bras M; de Thé H
J Cell Sci; 2007 Sep; 120(Pt 18):3219-27. PubMed ID: 17878236
[TBL] [Abstract][Full Text] [Related]
5. CRMP5-associated GTPase (CRAG) protein protects neuronal cells against cytotoxicity of expanded polyglutamine protein partially via c-Fos-dependent activator protein-1 activation.
Nagashima S; Fukuda T; Kubota Y; Sugiura A; Nakao M; Inatome R; Yanagi S
J Biol Chem; 2011 Sep; 286(39):33879-89. PubMed ID: 21832068
[TBL] [Abstract][Full Text] [Related]
6. PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins.
Janer A; Martin E; Muriel MP; Latouche M; Fujigasaki H; Ruberg M; Brice A; Trottier Y; Sittler A
J Cell Biol; 2006 Jul; 174(1):65-76. PubMed ID: 16818720
[TBL] [Abstract][Full Text] [Related]
7. Patient mutations alter ATRX targeting to PML nuclear bodies.
Bérubé NG; Healy J; Medina CF; Wu S; Hodgson T; Jagla M; Picketts DJ
Eur J Hum Genet; 2008 Feb; 16(2):192-201. PubMed ID: 17957225
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
[TBL] [Abstract][Full Text] [Related]
9. Puromycin-based vectors promote a ROS-dependent recruitment of PML to nuclear inclusions enriched with HSP70 and Proteasomes.
Moran DM; Shen H; Maki CG
BMC Cell Biol; 2009 May; 10():32. PubMed ID: 19409099
[TBL] [Abstract][Full Text] [Related]
10. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
[TBL] [Abstract][Full Text] [Related]
11. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
Engelhardt OG; Ullrich E; Kochs G; Haller O
Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
[TBL] [Abstract][Full Text] [Related]
12. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.
Ho CL; Huang YC; Tai CK; Liu ST; Wang JK; Wang WM; Huang SM
Int J Biochem Cell Biol; 2010 Jun; 42(6):902-10. PubMed ID: 20097304
[TBL] [Abstract][Full Text] [Related]
14. Calpain 5 is highly expressed in the central nervous system (CNS), carries dual nuclear localization signals, and is associated with nuclear promyelocytic leukemia protein bodies.
Singh R; Brewer MK; Mashburn CB; Lou D; Bondada V; Graham B; Geddes JW
J Biol Chem; 2014 Jul; 289(28):19383-94. PubMed ID: 24838245
[TBL] [Abstract][Full Text] [Related]
15. Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies.
Pankiv S; Lamark T; Bruun JA; Øvervatn A; Bjørkøy G; Johansen T
J Biol Chem; 2010 Feb; 285(8):5941-53. PubMed ID: 20018885
[TBL] [Abstract][Full Text] [Related]
16. Are promyelocytic leukaemia protein nuclear bodies a scaffold for caspase-2 programmed cell death?
Sanchez-Pulido L; Valencia A; Rojas AM
Trends Biochem Sci; 2007 Sep; 32(9):400-6. PubMed ID: 17693089
[TBL] [Abstract][Full Text] [Related]
17. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.
Reichelt M; Wang L; Sommer M; Perrino J; Nour AM; Sen N; Baiker A; Zerboni L; Arvin AM
PLoS Pathog; 2011 Feb; 7(2):e1001266. PubMed ID: 21304940
[TBL] [Abstract][Full Text] [Related]
18. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.
McFadden K; Hamilton RL; Insalaco SJ; Lavine L; Al-Mateen M; Wang G; Wiley CA
J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647
[TBL] [Abstract][Full Text] [Related]
19. Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia.
Torashima T; Koyama C; Iizuka A; Mitsumura K; Takayama K; Yanagi S; Oue M; Yamaguchi H; Hirai H
EMBO Rep; 2008 Apr; 9(4):393-9. PubMed ID: 18344973
[TBL] [Abstract][Full Text] [Related]
20. PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases.
Takahashi J; Fujigasaki H; Iwabuchi K; Bruni AC; Uchihara T; El Hachimi KH; Stevanin G; Dürr A; Lebre AS; Trottier Y; de Thé H; Tanaka J; Hauw JJ; Duyckaerts C; Brice A
Neurobiol Dis; 2003 Aug; 13(3):230-7. PubMed ID: 12901837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
